These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11672929)

  • 1. Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice.
    Hart MK; Lind C; Bakken R; Robertson M; Tammariello R; Ludwig GV
    Vaccine; 2001 Nov; 20(3-4):616-22. PubMed ID: 11672929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
    Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
    Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
    Bennett AM; Lescott T; Phillpotts RJ
    Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
    Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
    Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
    Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
    Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.
    Davis NL; Brown KW; Johnston RE
    J Virol; 1996 Jun; 70(6):3781-7. PubMed ID: 8648713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
    Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.
    Ludwig GV; Turell MJ; Vogel P; Kondig JP; Kell WK; Smith JF; Pratt WD
    Am J Trop Med Hyg; 2001; 64(1-2):49-55. PubMed ID: 11425162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
    Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
    J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine.
    Engler RJ; Mangiafico JA; Jahrling P; Ksiazek TG; Pedrotti-Krueger M; Peters CJ
    J Med Virol; 1992 Dec; 38(4):305-10. PubMed ID: 1474379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).
    Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B
    J Virol Methods; 2010 Feb; 163(2):424-32. PubMed ID: 19903494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.
    Jahrling PB; Stephenson EH
    J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.